| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 08/29/2001 | EP1127883A2 Oxamides as IMPDH inhibitors |
| 08/29/2001 | EP1127054A1 Novel inhibitors of impdh enzyme |
| 08/29/2001 | EP1126843A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 08/29/2001 | EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 08/29/2001 | CN1310714A Substituted benzoylcyclohexandiones |
| 08/29/2001 | CN1310179A Oxamide being as IMPDH inhibitor |
| 08/29/2001 | CN1309898A Pesticide containing 0-benzyl oximeether derivative and its use |
| 08/29/2001 | CN1070188C Process for producing D-(-)threo-2-oxazoline derivatives from L-substituted phenyl serine ester |
| 08/29/2001 | CN1070173C Benzoylaguanidine derivatives using as medicine |
| 08/28/2001 | US6281212 Chemokine receptor antagonists and methods of use therefor |
| 08/28/2001 | US6281210 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 08/28/2001 | US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied |
| 08/28/2001 | CA2054706C Very large scale immobilized polymer synthesis |
| 08/28/2001 | CA2017252C Retroviral protease inhibiting compounds |
| 08/24/2001 | CA2337588A1 Oxamides as impdh inhibitors |
| 08/23/2001 | WO2001060802A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
| 08/23/2001 | WO2001012625A3 Substituted benzoxazoles |
| 08/23/2001 | WO2001008479A3 High selective herbicidal phenoxypropionic acid alkoxycarbonyl anilid compounds and method of preparing thereof |
| 08/23/2001 | US20010016579 Serotonin 5-HT, receptor partial activator |
| 08/23/2001 | CA2399147A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | EP0907633B1 New synthetic catechol derivatives, method for production and use thereof |
| 08/22/2001 | CN1309650A Substd. diphenyl oxazolin derivs. with insecticidal effect |
| 08/22/2001 | CN1309325A Photographic element, compound and method |
| 08/21/2001 | US6277985 As antibiotics; water solubility; in prodrugs |
| 08/21/2001 | US6277869 Pharmaceutical composition |
| 08/21/2001 | US6277868 Bactericides; skin disorders |
| 08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 08/21/2001 | CA2000362C Methyl .alpha.-arylacrylates substituted by a heterocyclic radical and their use |
| 08/16/2001 | WO2001058890A1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 08/16/2001 | WO2001058885A1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/16/2001 | WO2001058871A1 Piperidyl carboxylic acids as integrin antagonists |
| 08/16/2001 | WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 08/16/2001 | WO2001058491A1 Drug comprising combination |
| 08/16/2001 | EP1123327A1 Solid supports containing scintillant |
| 08/16/2001 | EP1123284A1 Method for the preparation of citalopram |
| 08/16/2001 | EP1123282A2 Fragrance pro-accords and aldehyde and ketone fragrance libraries |
| 08/16/2001 | EP1123269A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123268A1 New compounds, their preparation and use |
| 08/16/2001 | EP0805817B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 08/16/2001 | EP0788498B1 Phenyloxazolidinone antimicrobials |
| 08/16/2001 | DE10006453A1 New piperidylcarboxylic acid derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological diseases, e.g. atherosclerosis, asthma, diabetes, rheumatoid arthritis or transplant rejection |
| 08/16/2001 | CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 08/16/2001 | CA2399463A1 Combination drug |
| 08/16/2001 | CA2395648A1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/15/2001 | CN1308620A Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308618A Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
| 08/15/2001 | CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1069640C Adhesion receptor antagonists |
| 08/14/2001 | US6274739 Chlorination of the corresponding benzoxazole compound in presence of an acid catalyst |
| 08/14/2001 | US6274605 Administering an insulin sensitivity enhancer with an angiotensin converting enzyme inhibitor to reduce side effects to a diabetic patient |
| 08/14/2001 | US6274600 Heteroatom substituted benzoyl derivatives that enhance synaptic responses mediated by AMPA receptors |
| 08/14/2001 | CA2168560C Substituted oxazine and thiazine oxazolidinone antimicrobials |
| 08/09/2001 | WO2001057035A1 Linezolid-crystal form ii |
| 08/09/2001 | WO2001057002A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | WO2001057001A1 Oxazolethoxyphenylpropanoic acid derivative as niddm- medicament |
| 08/09/2001 | WO2001056979A1 Substituted cyanoacetamide derivatives and herbicides |
| 08/09/2001 | WO2000005224A3 Heterocyclic derivatives and their use as integrin inhibitor |
| 08/09/2001 | CA2398674A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/08/2001 | EP1121129A1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION |
| 08/08/2001 | EP0798298B1 Thiazolidinone or oxazolidinone derivatives to treat angina pectoris or compositions containing the same as active ingredient |
| 08/07/2001 | US6271388 Process for producing oxazolidin-2-one derivative |
| 08/07/2001 | US6271387 Process for producing 1,3-oxazolidine derivatives |
| 08/07/2001 | US6271334 Sprayable coating compositions comprising oxazolidines and isocyanates |
| 08/07/2001 | US6271249 Diphenyl imidazoles as potassium channel modulators |
| 08/07/2001 | US6271243 Pharmaceutical composition |
| 08/02/2001 | WO2001055146A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 08/02/2001 | WO2001055060A2 Chiral ionic liquids |
| 08/02/2001 | WO2000066564A8 Benzimidazolones and analogues and their use as progesterone receptor ligands |
| 08/02/2001 | US20010011065 Azoline derivatives |
| 08/02/2001 | DE10003708A1 Neuartige chirale ionische Flüssigkeiten und Verfahren zu ihrer Darstellung in enantiomerenreiner oder enantiomerenangereicherter Form Novel chiral ionic liquids and methods for their representation in enantiomerically pure or enantiomerically enriched form |
| 08/01/2001 | EP1120161A1 High molecular weight ligands for homogeneously soluble asymmetric hydrogenation catalysts, process for their preparation and use thereof |
| 08/01/2001 | EP1119547A1 Substituted pyrrolidinone, thiazolidinone or oxazolidinone as herbicides |
| 08/01/2001 | CN1306525A Carboxylic acid of aza-heterocyclic compounds contg. multiple hetero-atoms or its electronic isosteric object |
| 07/31/2001 | US6268387 Inhibitors of the enzyme 15-lipoxygenase and are inhibitors of monocyte chemotaxis. |
| 07/31/2001 | US6268313 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 07/31/2001 | US6268312 Oxime derivative and bactericide containing the same as active ingredient |
| 07/26/2001 | WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2001052847A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 07/26/2001 | WO2001004097A3 Cyclic delocalized cations connected by spacer groups |
| 07/26/2001 | DE10002976A1 Molekulargewichtsvergrößerte Liganden für asymmetrische homogen lösliche Hydrierkatalysatoren, Verfahren zu deren Herstellung und Verwendung Molecular weight-ligands for asymmetric homogeneous hydrogenation catalysts soluble, to processes for their preparation and use |
| 07/26/2001 | CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 07/26/2001 | CA2397627A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 07/25/2001 | EP1118611A1 Process for the preparation of oxazolidinone derivative |
| 07/25/2001 | EP1117663A2 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP0854861B1 Oxyamino oxime ethers, methods and intermediate products for their production, and agents containing them and used for controlling harmful fungi and pests |
| 07/25/2001 | CN1305374A Oxazolidinones to treat eye infections |
| 07/24/2001 | US6265587 Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor |
| 07/24/2001 | US6265581 Reacting specified epoxide and amine, reacting product with acid to form acid addition salt |
| 07/24/2001 | US6265433 LTA4 hydrolase inhibitors |
| 07/24/2001 | US6265178 Incubating potential inhibitor with solubilized and purified monoamine oxidase in a buffer solution, adding 1-methyl-4-(1-methyl-2-pyrryl)-1,2,3,6-tetrahydropyridine, determining monoamine oxidase inhibitory activity |
| 07/24/2001 | CA2331993A1 Molecular weight-enlarged ligands for asymmetric, homogeneously soluble hydrogenation catalysts, process for the production thereof and use |
| 07/24/2001 | CA2171972C Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
| 07/19/2001 | WO2001051456A2 Antibacterial agents |
| 07/19/2001 | WO2001005391A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | US20010008902 Reduction of an unsaturated thiazolidine-2,4-dione derivative with metallic aluminum in a protic solvent; purity; antidiabetic agents |
| 07/19/2001 | US20010008898 Ether and amide compounds and preparation of thereof as antidiadetics. |
| 07/19/2001 | DE10100772A1 New heterocyclic-substituted phenyl ether or N-phenyl amide compounds, are low-toxicity antidiabetic agents having insulin potentiating and hypoglycemic activity |